Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 11/20 | 0.57 |
| ▸ | CES1 | P23141 | 7/20 | 0.57 |
| ▸ | CES2 | O00748 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6621021 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL31140192 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL6619179 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL28577564 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL28779284 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL11293992 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL4631696 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL10499113 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL6566731 | 0.98 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL6563264 | 0.98 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621243-B | Sulfonamide derivative and application thereof | 上海拓界生物医药科技有限公司 | 2024-03-01 | — | — | CN | disclosed |
| EP-4021444-A1 | KRAS G12D INHIBITORS | Mirati Therapeutics, Inc. (US) | 2022-07-06 | — | — | EP | disclosed |
| CN-114621243-A | Sulfonamide derivative and application thereof | 上海拓界生物医药科技有限公司 | 2022-06-14 | — | — | CN | disclosed |
| WO-2021041671-A1 | KRAS G12D INHIBITORS | Mirati Therapeutics, Inc. (US) | 2021-03-04 | — | — | WO | disclosed |
| EP-1212282-B1 | PRODUCTION OF ARYL CARBOXYLATE ESTERS | EASTMAN CHEM CO (US) | 2004-05-12 | — | — | EP | disclosed |
| CN-1387506-A | Preparation of aryl carboxylates | EASTMAN CHEM CO (US) | 2002-12-25 | — | — | CN | disclosed |
| US-6448431-B1 | BY REACTION OF A PHENOL WITH A CARBOXYLIC ANHYDRIDE OR ACID HALIDE IN THE PRESENCE OF TRIFLUOROACETIC ACID (TFA) AND TRIFLUOROACETIC ANHYDRIDE (TFAA); RELATIVELY LOW TEMPERATURE | EASTMAN CHEMICAL COMPANY | 2002-09-10 | — | — | US | disclosed |
| EP-1212282-A1 | PRODUCTION OF ARYL CARBOXYLATE ESTERS | EASTMAN CHEMICAL COMPANY (US) | 2002-06-12 | — | — | EP | disclosed |
| WO-2001019771-A1 | PRODUCTION OF ARYL CARBOXYLATE ESTERS | EASTMAN CHEMICAL COMPANY (US) | 2001-03-22 | — | — | WO | disclosed |